Specialist advice for Asian companies
Interpharm Home Page

Time for you to look at

the European market for generics

Your local markets are becoming very crowded. Prices that may seem low to you in your local market can be significantly higher in Europe. Interpharm has long experience of working with companies in India, China and Korea and is on a position to also help you to enter the European market with your products.

Many Indian, Korean and Chinese companies are looking to move up the value ladder from APIs to finished formulations. However, they run into difficulties when they encounter some of the barriers to entry. For example:-

  • GMP compliance - how do I ensure that my manufacturing facilities comply?
  • Product selection - which products should I be trying to sell and in which markets?
  • Partner selection - who should I be working with to get the best deal?
  • Registration - do I have enough of the right data to satisfy EU regulators?

Can you afford to wait for other local competitors to to continue eroding your local market share when you should be looking at Europe?

There is a solution - take the initiative now rather than responding to events and look at establishing yourself in Europe in the same way that the leading Indian and Korean companies have done.

Want to know where to start?

Interpharm Consultancy offers you:

  • In-depth knowledge of the European generic industry
  • Experience of establishing new generic business in Europe
  • Long experience of working with Asian pharmaceutical companies
  • Understanding of the differences between the Asian and European markets
  • Up-to-date knowledge of the latest European pharmaceutical legislation
  • Extensive contacts with the major players in the European generic industry
  • Clarification of how the European generic environment differs from the your own
  • Colleagues who can advise on GMP compliance and compiling CTD dossiers

We can be your bridge to Europe, allowing you to take advantage of the increasing levels of cross-border harmonisation.

European generics are going through a major growth phase right now by contrast with the ever more crowded US market. You can take advantage of this opportunity before your competitors spot what is happening.

Contact us now for more information:-

Auskunft auf Deutsch (Information in German)
Informations en Français (French language information)
Web Design
[Interpharm Home] [Services] [Advice for Asian companies] [Interpharm - Auskunft auf Deutsch] [Interpharm - Quelques informations en Français] [News] [Bioequivalence] [Recent Article] [About Interpharm Consultancy] [Curriculum Vitae] [Contact us]